We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Joint Committee on Vaccination and Immunisation (JCVI) has provided interim advice to government regarding coronavirus (COVID-19) booster doses this autumn.
The JCVI is advising that people with severely weakened immune systems should have a third vaccine dose as part of their primary COVID-19 vaccination schedule.
Following the emergence of the Omicron variant, including confirmed cases in the UK, JCVI has urgently reviewed vaccine response measures.
JCVI has advised that, in addition to those aged over 50 years and at higher risk from coronavirus, all adults aged 40 to 49 years should be offered an mRNA booster.
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the government on the use of COVID-19 vaccines to mitigate the impact of the B1.617.2 variant of concern.
JCVI makes interim recommendations to government on the COVID-19 vaccination programme for 2023.
The Joint Committee on Vaccination and Immunisation (JCVI) has updated its vaccination advice for children aged 5 to 11, with a view to increasing protection against potential future waves of coronavirus (COVID-19).
All of the available boosters provide good protection against severe illness from coronavirus (COVID-19).
The Joint Committee on Vaccination and Immunisation (JCVI) has considered the evidence for Phase 2 of the UK’s COVID-19 vaccination programme.
Health and Social Care Secretary Sajid Javid accepted advice from the Joint Committee on Vaccination and Immunisation (JCVI) on Wednesday 22 December 2021.
Slides presented by Professor Wei Shen Lim, Chair of the Joint Committee on Vaccination and Immunisation (JCVI) and Dr Mary Ramsay, Head of Immunisations, Public Health England.
A joint statement from the 4 UK health ministers on JCVI advice for phase 2 of the COVID-19 vaccination programme.
JCVI has advised the government to invite all people on the GP Learning Disability Register for COVID-19 vaccination.
Vaccinations are to be offered to 5 to 11 year olds who are at higher risk from coronavirus (COVID-19).
Health and Social Care Secretary accepts independent advice to extend booster programme to people aged 40 and over, and offer a second dose to people aged 16 to 17.
Impact assessment into the cost effectiveness of the COVID-19 autumn 2023 vaccination programme.
JCVI recommends that adults living with adults who are immunosuppressed should be prioritised for the COVID-19 vaccine.
Health ministers from the 4 nations have asked the UK's chief medical officers to advise on the vaccination of young people aged 12 to 15.
The Joint Committee on Vaccination and Immunisation (JCVI) has been asked to consider the options for a potential coronavirus (COVID-19) booster programme.
Health and Social Care Secretary Sajid Javid accepts advice from JCVI to offer COVID-19 vaccination to those aged 16 and 17.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).